Fear of cancer may have unwanted effect on public screening uptake
the ONA take:
People who worry about developing cancer are more likely to want to undergo screening for colon cancer; however, according to new research from the Cancer Research UK Health Behaviour Research Centre at UCL, that fear makes them less likely to actually go for the test.
Research to date has used a combined measure of cancer fear, which does not explain how fear results in such different actions. In this study, the researchers distinguished different aspects of fear to see whether it had different effects on people’s decisions about cancer screening.
Approximately 2,000 participants were randomized to receive a screening invitation. Clinical records show that 71% actually attended; 68% of those who reported feeling uncomfortable thinking about cancer attended screening, compared with 77% of those who did not feel uncomfortable.
The research findings suggest that public service announcements about colon cancer screening need to focus more on the preventive value of screening than increasing public fear of cancer.
People who worry about developing cancer are more likely to want to undergo screening for colon cancer.
- Prolonged Imatinib Therapy Improves Likelihood of Deeper Molecular Response
- Ruxolitinib Effective as Long-term Treatment Option for Polycythemia Vera
- Study Affirms Activity of Ibrutinib in Patients With R/R CLL With 17p Deletion
- Patients Receiving RT in APBI Facilities Despite Eligibility for Observation
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- Longer Maintenance Therapy Duration May Improve Survival in Myeloma
- HRQoL Better Maintained With Pembrolizumab in Ipilimumab-refractory Melanoma
- Economic Evaluation of Obinutuzumab in Combination With Chlorambucil in First-line Treatment of Patients With Chronic Lymphocytic Leukemia in Spain
- MRD Assessment Improves PFS Prediction in Patients With CLL
- Cancer Patients Have Unrealistic Hopes When Entering Clinical Trials
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|